SCOREGRUBResearch desk
Sources live19 USDC · 30 days · no renewalCheckout readyResearch only · no order execution
← Back to Markets
Market report

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?

KXFDAAPPROVE-MDMA-32JAN01 · General · closes December 31, 2031

Open market source ↗
YES ask
58¢
Current public quote
NO ask
48¢
Current public quote
Volume
1,073
Contracts
Open interest
1,062
Contracts

YES 58¢NO 42¢

Source Kalshi public market dataRetrieved Boundary Research only; no order is placed
Source-bound analysis

Reviewed Research Report

Load the latest source-bound report after retrieval and review.

Simulated portfolio

Track a paper position

This saves a no-cash-value position to your Member Desk. It sends no order.

External execution

Continue at a venue

Use your separately approved external account. ScoreGrub sends no quantity, price, side, credentials, funds, or order.

View partner venues ↗